MedPath

Metabolic Syndrome Prevalence Study

Completed
Conditions
Metabolic Syndrome
Registration Number
NCT02379702
Lead Sponsor
Abdi Ibrahim Ilac San. ve Tic A.S.
Brief Summary

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Detailed Description

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1659
Inclusion Criteria
  • Volunteers who participated in the METSAR-I study in 2003
  • Patients who accepted to participate will be included the second follow up phase.
Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comorbidities and changes in general health10 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Ankara University

🇹🇷

Ankara, Turkey

Gazi University

🇹🇷

Ankara, Turkey

Prof. Dr. Omer Kozan

🇹🇷

İzmir, Turkey

Istanbul Cerrahpasa University

🇹🇷

Istanbul, Turkey

Istanbul Medeniyet University

🇹🇷

Istanbul, Turkey

Yuksek Ihtisas Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath